| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 56.033 | 51.789 | 20.818 | 38.773 | 51.546 | 65.626 | 48.037 |
| Total Income - EUR | - | - | - | 56.033 | 51.789 | 20.818 | 38.773 | 51.546 | 65.626 | 48.037 |
| Total Expenses - EUR | - | - | - | 5.330 | 6.652 | 4.942 | 3.401 | 1.104 | 16.282 | 14.127 |
| Gross Profit/Loss - EUR | - | - | - | 50.703 | 45.137 | 15.876 | 35.371 | 50.443 | 49.345 | 33.910 |
| Net Profit/Loss - EUR | - | - | - | 49.022 | 43.584 | 15.292 | 34.208 | 49.162 | 48.688 | 32.468 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Adi Sol Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 79 | 39 | 971 | 454 | 0 | 1.415 | 1.045 |
| Current Assets | - | - | - | 49.547 | 43.976 | 14.736 | 48.536 | 49.791 | 49.107 | 33.553 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 0 | 0 | 0 | 36.500 | 34.927 | 23.893 |
| Cash | - | - | - | 49.547 | 43.976 | 14.736 | 48.536 | 13.290 | 14.180 | 9.660 |
| Shareholders Funds | - | - | - | 49.065 | 43.652 | 15.529 | 34.440 | 49.440 | 48.965 | 32.744 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 561 | 363 | 3.631 | 14.550 | 351 | 1.557 | 1.855 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Adi Sol Med S.r.l.